237 related articles for article (PubMed ID: 26875774)
41. cFLIP overexpression in T cells in thymoma-associated myasthenia gravis.
Belharazem D; Schalke B; Gold R; Nix W; Vitacolonna M; Hohenberger P; Roessner E; Schulze TJ; Saruhan-Direskeneli G; Yilmaz V; Ott G; Ströbel P; Marx A
Ann Clin Transl Neurol; 2015 Sep; 2(9):894-905. PubMed ID: 26401511
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-125a-5p induces mouse granulosa cell apoptosis by targeting signal transducer and activator of transcription 3.
Wang C; Li D; Zhang S; Xing Y; Gao Y; Wu J
Menopause; 2016 Jan; 23(1):100-7. PubMed ID: 26154273
[TBL] [Abstract][Full Text] [Related]
43. Aberrant decrease of microRNA19b regulates TSLP expression and contributes to Th17 cells development in myasthenia gravis related thymomas.
Wang Z; Chen Y; Xu S; Yang Y; Wei D; Wang W; Huang X
J Neuroimmunol; 2015 Nov; 288():34-9. PubMed ID: 26531692
[TBL] [Abstract][Full Text] [Related]
44. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
45. Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients.
Rezaeepoor M; Pourjafar M; Tahamoli-Roudsari A; Basiri Z; Hajilooi M; Solgi G
Int Immunopharmacol; 2020 Jun; 83():106404. PubMed ID: 32197230
[TBL] [Abstract][Full Text] [Related]
46. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
47. Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses.
Li S; Wang X; Wang T; Zhang H; Lu X; Liu L; Li L; Bo C; Kong X; Xu S; Ning S; Wang J; Wang L
J Transl Med; 2021 Nov; 19(1):468. PubMed ID: 34794447
[TBL] [Abstract][Full Text] [Related]
48. Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis.
Coppedè F; Stoccoro A; Nicolì V; Gallo R; De Rosa A; Guida M; Maestri M; Lucchi M; Ricciardi R; Migliore L
Gene; 2020 Aug; 752():144774. PubMed ID: 32442579
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
50. miR-125a-5p impairs endothelial cell angiogenesis in aging mice via RTEF-1 downregulation.
Che P; Liu J; Shan Z; Wu R; Yao C; Cui J; Zhu X; Wang J; Burnett MS; Wang S; Wang J
Aging Cell; 2014 Oct; 13(5):926-34. PubMed ID: 25059272
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
Jiang L; Huang Q; Chang J; Wang E; Qiu X
Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
[TBL] [Abstract][Full Text] [Related]
52. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.
Rouas R; Fayyad-Kazan H; El Zein N; Lewalle P; Rothé F; Simion A; Akl H; Mourtada M; El Rifai M; Burny A; Romero P; Martiat P; Badran B
Eur J Immunol; 2009 Jun; 39(6):1608-18. PubMed ID: 19408243
[TBL] [Abstract][Full Text] [Related]
53. A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.
Ghafouri-Fard S; Azimi T; Hussen BM; Taheri M; Jalili Khoshnoud R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884767
[TBL] [Abstract][Full Text] [Related]
54. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
56. Levels of miR-125a-5p are altered in Mycobacterium avium-infected macrophages and associate with the triggering of an autophagic response.
Wang Y; Chen C; Xu XD; Li H; Cheng MH; Liu J; Tang LJ
Microbes Infect; 2020; 22(1):31-39. PubMed ID: 31349052
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-125a-5p Affects Adipocytes Proliferation, Differentiation and Fatty Acid Composition of Porcine Intramuscular Fat.
Du J; Xu Y; Zhang P; Zhao X; Gan M; Li Q; Ma J; Tang G; Jiang Y; Wang J; Li X; Zhang S; Zhu L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414921
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
[TBL] [Abstract][Full Text] [Related]
59. MiR-125a-5p Alleviates Dysfunction and Inflammation of Pentylenetetrazol- induced Epilepsy Through Targeting Calmodulin-dependent Protein Kinase IV (CAMK4).
Liu Q; Wang L; Yan G; Zhang W; Huan Z; Li J
Curr Neurovasc Res; 2019; 16(4):365-372. PubMed ID: 31490757
[TBL] [Abstract][Full Text] [Related]
60. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
